Document is current
Any future updates will be listed below
-
Authors
Salimi, Yazdan
Shiri, Isaac
Mansouri, Zahra
Sanaat, Amirhossein
Hajianfar, Ghasem
Hervier, Elsa
Bitarafan, Ahmad
Caobelli, Federico
Hundertmark, Moritz
Mainta, Ismini
Gräni, Christoph
Nkoulou, René
Zaidi, Habib https://orcid.org/0000-0001-7559-5297
-
Funding
Funding for this research was provided by:
University of Geneva
- License Information
-
More Information
Article History
Received: 12 September 2024
Accepted: 24 January 2025
First Online: 5 February 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics committee of the Canton of Geneva, Switzerland. Consent forms were waived owing to the retrospective nature of the study.
: Informed consent was obtained from all individual participants included in the study.
: All authors approved the final version of the manuscript and consent to give the Publisher the permission to publish the work.
: The University Hospital Bern receives funding from AstraZeneca and Pfizer for the Bern Amyloidosis Registry (B-CARE) (NCT04776824). Dr Caobelli is currently supported by a research grant by Siemens Healthineers and receives speakers Honoraria by Bracco AG and Pfizer AG for matters not related to the present manuscript. Prof. Zaidi received funding from General Electric Healthcare not related to the present manuscript. Dr Federico Caobelli is an Editor (Guest Editor) of EJNMMI.
